Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (721-730 of 968) with videos related to

Pageof 97
Sort By:
British Journal of Haematology|October 12, 2013
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myelomaJonathan L Kaufman, Ruben Niesvizky, Edward A Stadtmauer, et al.
Clinical Chemistry|January 1, 1989
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigenH J Hansen, G LaFontaine, E S Newman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphomaRhona Stein, Zhengxing Qu, Susan Chen, et al.
Bioconjugate Chemistry|September 19, 2002
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigenH Karacay, R M Sharkey, W J McBride, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2017
Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor ModelMarlène C H Hekman, Mark Rijpkema, Desirée L Bos, et al.
International Journal of Cancer|August 15, 2003
Experimental radioimmunotherapy of small peritoneal metastases of colorectal originManuel J Koppe, Annemieke C Soede, Wikke Pels, et al.
International Journal of Cancer|February 8, 1995
Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation siteS O Leung, A S Dion, M C Pellegrini, et al.
The New England Journal of Medicine|August 10, 1989
The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnanciesE Schiff, E Peleg, M Goldenberg, et al.
Addictive Behaviors|February 4, 2015
Short-term cessation of sex work and injection drug use: evidence from a recurrent event survival analysisTommi L Gaines, Lianne A Urada, Gustavo Martinez, et al.
SSM. Mental Health|May 7, 2026
Adverse migration experiences, border community stress, and the mental health of asylum-seeking women in transit at the Mexico-U.S. borderShira M Goldenberg, Kayla Saadeh, Kaylee Ramage, et al.
Pageof 97

Showing results (721-730 of 968) with videos related to

Sort By:
Pageof 97
British Journal of Haematology|October 12, 2013
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myelomaJonathan L Kaufman, Ruben Niesvizky, Edward A Stadtmauer, et al.
Clinical Chemistry|January 1, 1989
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigenH J Hansen, G LaFontaine, E S Newman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphomaRhona Stein, Zhengxing Qu, Susan Chen, et al.
Bioconjugate Chemistry|September 19, 2002
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigenH Karacay, R M Sharkey, W J McBride, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2017
Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor ModelMarlène C H Hekman, Mark Rijpkema, Desirée L Bos, et al.
International Journal of Cancer|August 15, 2003
Experimental radioimmunotherapy of small peritoneal metastases of colorectal originManuel J Koppe, Annemieke C Soede, Wikke Pels, et al.
International Journal of Cancer|February 8, 1995
Effect of VK framework-1 glycosylation on the binding affinity of lymphoma-specific murine and chimeric LL2 antibodies and its potential use as a novel conjugation siteS O Leung, A S Dion, M C Pellegrini, et al.
The New England Journal of Medicine|August 10, 1989
The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnanciesE Schiff, E Peleg, M Goldenberg, et al.
Addictive Behaviors|February 4, 2015
Short-term cessation of sex work and injection drug use: evidence from a recurrent event survival analysisTommi L Gaines, Lianne A Urada, Gustavo Martinez, et al.
SSM. Mental Health|May 7, 2026
Adverse migration experiences, border community stress, and the mental health of asylum-seeking women in transit at the Mexico-U.S. borderShira M Goldenberg, Kayla Saadeh, Kaylee Ramage, et al.
Pageof 97